ORYZON receives approval from MHRA to initiate Clinical Development of ORY-1001, a Novel LSD1 Inhibitor, in Patients with Acute Myeloid Leukemia in the United Kingdom

Substance abuse Agrobiotechnology Food - Substance detection Animal food - Feed Functional food Analgesia & pain Associations Biobanks Bioclusters Biofuels Biodrugs Bioinformatics Cellular and molecular biology Systems biology Evolutionary biology Synthetic biology Biomarkers Biomaterials Marine-based biotechnology Business Angels Cancer Stem cells Cardiovascular and circulatory system Research Centers Private clinic Communication & Media Consultancy Biologic control (plagues...) Quality control Corporate investor Cosmetics Cell culture GM Crops Biological defense Dental Dermatology Muskuloskeletal disorders Biotechnology kits Software development Diagnostic - Imaging Medical Devices Drug Delivery Drug development Drug discovery Pregnancy, reproduction Venture capital management company Energy Bone diseases Chronic diseases Degenerative diseases Genetic diseases Hereditary diseases Inflamatory diseases Neurologic Diseases Rares diseases Clinical trials Public entity Epidemiology Epigenetics Medical and surgical equipment Patient monitoring equipment Manufacture of biotech equipment Manufacter of resins to purification Manufacture and commercialization of fermentation or biocatalysis Manufacture and commercialization of enzymes Manufacture and commercialization of cell lines Manufacture and commercialization microorganism Manufacture of APIs and chemical products from renewable raw material Manufacture of monomers and polymers Pharmacy Pharmacogenomics Public financing Investment Funds Training Foundatio Foundation Genomics Hospitals Infections Engineering Immunology Healthcare facilities and services Scientific & Technical instruments Internet and information technologies Institutional investor Private investor Leasing Environmental cleanup - testing Maintenance cell cultures Sales & Marketing Environment Metabolomics Microbiology Nanotechnology Neuroscience Nutrition Oftalmology Cost optimization Other enhancement techniques (molecular marker..) Peptides Science - Technology parks Probiotics Blood products Disposable medical products Industrial property, patents & trademarks Proteins Proteomics DNA tests Diagnostic tests Scientific publications Chemistry Human Resources Research network Residues revaloration and bioremed Animal health Women's health Child health Mental health Senior health Healthy Blood and lymphatic system Screening Food Safety CRO - CMO Services Research services and supplies Legal services Auditory system Digestive system Kidney and genitourinary system Locomotive system Metabolic system - endocrinology Central Nervous System Respiratory and pulmonary system Laser Optical Systems Cellular Therapy Gene Therapy Tissue therapy Toxicology Technology transfer Transplant Universities Vaccines Venture capital Vitamins and nutrition products Viral vector

Substance abuse Agrobiotechnology Food - Substance detection Animal food - Feed Functional food Analgesia & pain Associations Biobanks Bioclusters Biofuels Biodrugs Bioinformatics Cellular and molecular biology Systems biology Evolutionary biology Synthetic biology Biomarkers Biomaterials Marine-based biotechnology Business Angels Cancer Stem cells Cardiovascular and circulatory system Research Centers Private clinic Communication & Media Consultancy Biologic control (plagues...) Quality control Corporate investor Cosmetics Cell culture GM Crops Biological defense Dental Dermatology Muskuloskeletal disorders Biotechnology kits Software development Diagnostic - Imaging Medical Devices Drug Delivery Drug development Drug discovery Pregnancy, reproduction Venture capital management company Energy Bone diseases Chronic diseases Degenerative diseases Genetic diseases Hereditary diseases Inflamatory diseases Neurologic Diseases Rares diseases Clinical trials Public entity Epidemiology Epigenetics Medical and surgical equipment Patient monitoring equipment Manufacture of biotech equipment Manufacter of resins to purification Manufacture and commercialization of fermentation or biocatalysis Manufacture and commercialization of enzymes Manufacture and commercialization of cell lines Manufacture and commercialization microorganism Manufacture of APIs and chemical products from renewable raw material Manufacture of monomers and polymers Pharmacy Pharmacogenomics Public financing Investment Funds Training Foundatio Foundation Genomics Hospitals Infections Engineering Immunology Healthcare facilities and services Scientific & Technical instruments Internet and information technologies Institutional investor Private investor Leasing Environmental cleanup - testing Maintenance cell cultures Sales & Marketing Environment Metabolomics Microbiology Nanotechnology Neuroscience Nutrition Oftalmology Cost optimization Other enhancement techniques (molecular marker..) Peptides Science - Technology parks Probiotics Blood products Disposable medical products Industrial property, patents & trademarks Proteins Proteomics DNA tests Diagnostic tests Scientific publications Chemistry Human Resources Research network Residues revaloration and bioremed Animal health Women's health Child health Mental health Senior health Healthy Blood and lymphatic system Screening Food Safety CRO - CMO Services Research services and supplies Legal services Auditory system Digestive system Kidney and genitourinary system Locomotive system Metabolic system - endocrinology Central Nervous System Respiratory and pulmonary system Laser Optical Systems Cellular Therapy Gene Therapy Tissue therapy Toxicology Technology transfer Transplant Universities Vaccines Venture capital Vitamins and nutrition products Viral vector